Saturday, October 01, 2022 11:09:40 AM
Lots of good things in the recent podcast.. I was tempted to do a point by point summary (might still do one if I get bored later this weekend).. but any serious shareholder should take the roughly 10 minutes it takes to hear the update straight from Ken Tapp himself (the CEO).. the link to the recorded podcast is on this board.
For those who are not familiar with the process or types of things that occur before a company uplists or goes public.. there is usually a roadshow to present to analysts, larger investors (institutional) and retail. Ken talked about this occurring in the coming weeks (and btw for those expecting a "blackout" in company information, it looks like we have more communication to look forward to according to Ken, starting with Oct. 11, 12.. might actually get some interesting pieces of info in those investor decks:).. also it was projected that filings will be accelerated for this next quarter so we won't need to be in the quiet period for very long.
Record revenue.. collected all ACs (account receivables).. and revenue looks to be growing going forward. No further dilution leading into the UPLISTING according to Ken.. which is exciting considering everything else that is taking place (they had previously considered raising the share count by 2 billion)..
What really excites me is thinking about the 15 percent stake in each of these incubator companies in addition to the 5 percent going forward.. and how there is going to be a multiplyer effect in 2023 and going forward into the future. The number of potential liquidity events is going to GREATLY expand.. and then add the extra revenue stream on top of that and you can see the power of this business model. We are currently at such a small market cap.. it's not hard to see the huge opportunity for growth!
I like the heads up on the office expansion:).. supports this idea of needing more space for this obvious expansion. Very bullish:)
Again could say more.. but people should seriously listen to Ken's own words. I clearly don't understand the naysayers perspective in light of what we now know about WDLF. Very solid company, management and plan going forward. Ken took away a lot of the ammunition (announcing record revenue, cash now on the books, no dilution, continued communication to look forward to (no significant quiet period).. VERY impressive progress being made!
Very proud to be a WDLF shareholder!:)
Cy
This is my opinion.. please do your own DD.. this is not investment advice.. I simply try to find the best companies to put my
money.. and I post on boards where I either have an interest in the stock or own shares.
Recent WDLF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:26:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:03:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:57:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 12:50:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 02:00:10 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/08/2023 06:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:41:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 08:13:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 10:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:52:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 01:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 06:57:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 09:25:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 12:00:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/14/2023 08:57:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:39:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM